Bristol Myers Squibb (BMY) Shares Outstanding (2009 - 2026)

Bristol Myers Squibb (BMY) has 18 years of Shares Outstanding data on file, last reported at $2.9 billion in Q1 2026.

• Quarterly Shares Outstanding changed 0.0% year-over-year to $2.9 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $2.9 billion (changed 0.0% YoY) and the FY2025 annual result came in at $2.9 billion, changed 0.0% from the prior year.
• Shares Outstanding held at $2.9 billion in Q1 2026 per BMY's latest filing, from $2.9 billion in the prior quarter.
• Across five years, Shares Outstanding topped out at $2.9 billion in Q1 2022 and bottomed at $2.9 billion in Q1 2022.
• The 5-year median for Shares Outstanding is $2.9 billion (2022), against an average of $2.9 billion.
• Peak annual rise in Shares Outstanding reached 322.4% in 2022, while the deepest fall reached 0.0% in 2022.
• Tracing BMY's Shares Outstanding over 5 years: stood at $2.9 billion in 2022, then changed by 0.0% to $2.9 billion in 2023, then changed by 0.0% to $2.9 billion in 2024, then changed by 0.0% to $2.9 billion in 2025, then changed by 0.0% to $2.9 billion in 2026.
• Per Business Quant, the three latest BMY Shares Outstanding figures stand at $2.9 billion (Q1 2026), $2.9 billion (Q4 2025), and $2.9 billion (Q3 2025).

Peer Comparison